Related Articles
Potent and specific fusion toxins consisting of a HER2‑binding, ABD‑derived affinity protein, fused to truncated versions of Pseudomonas exotoxin A
Influence of molecular design on biodistribution and targeting properties of an Affibody-fused HER2-recognising anticancer toxin
Imaging agents for in vivo molecular profiling of disseminated prostate cancer: Cellular processing of [111In]-labeled CHX-A''DTPA-trastuzumab and anti-HER2 ABY-025 Affibody in prostate cancer cell lines
Suppression of human epidermal growth factor receptor 2 via interference increases the chemosensitivity of ovarian carcinoma
Effects of affinity on binding of HER2-targeting Affibody molecules: Model experiments in breast cancer spheroids